Maxim Biotechnologies is Diagnostic Equipment in China that focus on immunohistochemical diagnostic reagents business. Founded in 1993. They cover business area such as tumor, testing instrument, immunocytochemical diagnosis, molecular pathological diagnosis, medical diagnosis, medical institute, medical detection accuracy, cost.
1993
( 31 years old in 2024 )
Immunohistochemical Diagnostic Reagents
-
Building 12, Haixi Innovation Park
High-tech Zone, Wulongjiang Middle Avenue
Fuzhou, Fujian
China
Private
tumortesting instrumentimmunocytochemical diagnosismolecular pathological diagnosismedical diagnosismedical institutemedical detection accuracycost
* We use standard office opening hours in near Maxim Biotechnologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Maxim Biotechnologies is Diagnostic Equipment business from China that founded in 1993 (31 years old in 2024), Maxim Biotechnologies business is focusing on Immunohistochemical Diagnostic Reagents.
Maxim Biotechnologies headquarter office and corporate office address is located in Building 12, Haixi Innovation Park High-tech Zone, Wulongjiang Middle Avenue Fuzhou, Fujian China.
Maxim Biotechnologies was founded in China.
In 2024, Maxim Biotechnologies is currently focus on immunohistochemical diagnostic reagents sector.
Above is snippet of Google Trends for "immunohistochemical diagnostic reagents" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Maxim Biotechnologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
